No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Here's Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10
This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
Top Premarket Decliners
William Blair Downgrades Applied Therapeutics to Market Perform
William Blair Downgrades Applied Therapeutics(APLT.US) to Hold Rating
RBC Capital Maintains Applied Therapeutics(APLT.US) With Hold Rating, Cuts Target Price to $1.5